Bitcoin News Today: KindlyMD Faces Nasdaq Delisting Threat as Shares Sink to 38-Cent Low

Nasdaq has issued a warning to KindlyMD, a publicly traded Bitcoin treasury firm, over its shares trading below $1 for 30 consecutive trading days. The exchange granted the company until June 8, 2026 to raise its stock price to $1 or more for 10 consecutive days to avoid potential delisting. KindlyMD's stock closed at $0.38 recently, marking a fresh low following a sharp decline from its May peak as reported. The firm, which operates under the ticker NAKA, now faces mounting pressure to stabilize its equity value.

The company's troubles intensified after a reverse merger with Nakamoto in August, which shifted its focus to a Bitcoin treasury strategy. Shares soared initially but have since fallen nearly 99%, partly due to unlocked restricted shares and delayed financial reporting. CEO David Bailey acknowledged the uncertainty in a shareholder letter, urging short-term traders to reconsider their positions. These developments have eroded investor confidence, compounding the firm's delisting risk.

KindlyMD holds a substantial Bitcoin portfolio of 5,398 BTC, valued at approximately $474 million. This positions the firm as the 19th largest corporate holder of Bitcoin globally.

Despite the size of its digital assets, its market capitalization has plummeted to $256 million, highlighting a growing disconnect between its crypto holdings and equity valuation. The firm's financial leverage and recent $210 million loan from Kraken further underscore the precariousness of its capital structure.

Why the Standoff Happened

KindlyMD's decline began after the September unlocking of restricted shares from its $200 million fundraising, which triggered a wave of selling pressure. The company's share price had previously surged on the back of its merger with Nakamoto, but the subsequent volatility exposed weaknesses in its capital structure. In November, the firm also delayed its Q3 earnings report due to complex accounting challenges, further deepening uncertainty among investors. These events collectively contributed to a loss of momentum in its stock price.

Nasdaq's delisting rules require listed companies to maintain a minimum bid price of $1 for 10 consecutive trading days. KindlyMD now has a compliance window until June 8, 2026, but the exchange may require the firm to meet the threshold for up to 20 trading days before confirming compliance. If the company fails to act within the timeframe, it could face delisting or a transfer to the Nasdaq Capital Market, a process requiring additional fees and regulatory approvals.

How Markets Reacted

The broader market has responded to the news with cautious interest, as KindlyMD's situation highlights the challenges of valuing Bitcoin treasury firms in traditional equity markets. Analysts note that crypto-linked equities often face unique headwinds, including regulatory uncertainty and liquidity challenges. One market observer stated that publicly traded Bitcoin holders must navigate both crypto volatility and traditional exchange compliance, creating a dual layer of risk for investors.

The firm's stock has mirrored the broader turbulence in crypto-related equities, with many investors wary of the sector's regulatory environment. KindlyMD's 5,398 BTC holdings serve as both an asset and a liability, as Bitcoin's price swings can amplify equity volatility. While the firm's Bitcoin position is valued at nearly $475 million, its stock price has not reflected that value, raising questions about market perception and capitalization methods.

What This Means for Investors

For investors, the situation presents both risk and opportunity. If KindlyMD fails to regain compliance with Nasdaq's pricing rules, its shares may transfer to over-the-counter markets or be delisted entirely, reducing liquidity and visibility. However, the firm's Bitcoin treasury could serve as a stabilizing force, particularly if Bitcoin's price recovers. The company may also explore a reverse stock split or seek to extend its compliance period by transferring to the Nasdaq Capital Market, though these options come with their own costs and uncertainties.

Investors are advised to monitor KindlyMD's SEC filings and financial updates closely. The firm's ability to manage its capital structure, communicate with shareholders, and respond to market pressures will be critical in determining its future. Meanwhile, the broader landscape of Bitcoin treasury firms remains under scrutiny, with regulatory and operational hurdles shaping the path forward for the sector. As the compliance deadline approaches, all eyes will be on how KindlyMD navigates its delisting risk.